| Triumeq |
Human |
abacavir;dolutegravir;lamivudine |
dolutegravir sodium;lamivudine;abacavir (as sulfate) |
EMEA/H/C/002754 |
ViiV Healthcare B.V. |
2014/08/31
|
Authorised |
| Velphoro |
Human |
sucroferric oxyhydroxide |
sucroferric oxyhydroxide |
EMEA/H/C/002705 |
Vifor Fresenius Medical Care Renal Pharma France |
2014/08/26
|
Authorised |
| Vizamyl |
Human |
flutemetamol (18F) |
flutemetamol (18F) |
EMEA/H/C/002557 |
GE Healthcare AS |
2014/08/22
|
Authorised |
| Daklinza |
Human |
daclatasvir |
daclatasvir dihydrochloride |
EMEA/H/C/003768 |
Bristol-Myers Squibb Pharma EEIG |
2014/08/22
|
Expired |
| Translarna |
Human |
ataluren |
ataluren |
EMEA/H/C/002720 |
PTC Therapeutics International Limited |
2014/07/31
|
Expired |
| Gazyvaro |
Human |
obinutuzumab |
obinutuzumab |
EMEA/H/C/002799 |
Roche Registration GmbH |
2014/07/22
|
Authorised |
| Nuwiq |
Human |
simoctocog alfa |
simoctocog alfa |
EMEA/H/C/002813 |
Octapharma AB |
2014/07/22
|
Authorised |
| Plegridy |
Human |
peginterferon beta-1a |
peginterferon beta-1a |
EMEA/H/C/002827 |
Biogen Netherlands B.V. |
2014/07/18
|
Authorised |
| Simbrinza |
Human |
brinzolamide;brimonidine tartrate |
brinzolamide;brimonidine tartrate |
EMEA/H/C/003698 |
Novartis Europharm Limited |
2014/07/18
|
Authorised |
| Envarsus |
Human |
tacrolimus |
tacrolimus |
EMEA/H/C/002655 |
Chiesi Farmaceutici S.p.A. |
2014/07/18
|
Authorised |
| Mekinist |
Human |
trametinib |
trametinib |
EMEA/H/C/002643 |
Novartis Europharm Limited |
2014/06/30
|
Authorised |
| Entyvio |
Human |
vedolizumab |
vedolizumab |
EMEA/H/C/002782 |
Takeda Pharma A/S |
2014/05/22
|
Authorised |
| Sylvant |
Human |
siltuximab |
siltuximab |
EMEA/H/C/003708 |
Recordati Netherlands B.V. |
2014/05/22
|
Authorised |
| Ebilfumin |
Human |
oseltamivir |
oseltamivir |
EMEA/H/C/003717 |
Actavis Group PTC ehf |
2014/05/22
|
Authorised |
| Jardiance |
Human |
empagliflozin |
empagliflozin |
EMEA/H/C/002677 |
Boehringer Ingelheim International GmbH |
2014/05/22
|
Authorised |
| Olysio |
Human |
simeprevir |
simeprevir |
EMEA/H/C/002777 |
Janssen-Cilag International NV |
2014/05/14
|
Withdrawn |
| Laventair Ellipta (previously Laventair) |
Human |
umeclidinium bromide;vilanterol |
umeclidinium bromide;vilanterol |
EMEA/H/C/003754 |
GlaxoSmithKline Trading Services Limited |
2014/05/08
|
Authorised |
| Anoro Ellipta (previously Anoro) |
Human |
umeclidinium bromide;vilanterol |
umeclidinium bromide;vilanterol trifenatate |
EMEA/H/C/002751 |
GlaxoSmithKline Trading Services Limited |
2014/05/08
|
Authorised |
| Revinty Ellipta |
Human |
fluticasone furoate;vilanterol |
fluticasone furoate;vilanterol trifenatate |
EMEA/H/C/002745 |
GlaxoSmithKline Trading Services Limited |
2014/05/02
|
Authorised |
| Incruse Ellipta (previously Incruse) |
Human |
umeclidinium bromide |
umeclidinium bromide |
EMEA/H/C/002809 |
GlaxoSmithKline Trading Services Limited |
2014/04/28
|
Authorised |